Ancora Advisors, LLC Finch Therapeutics Group, Inc. Transaction History

Ancora Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.75 - $51.3 $27,555 - $807,769	-15,746 Reduced 49.6%	16,000 $27,000
Q2 2022 Aug 15, 2022	BUY	$1.91 - $5.11 $30,560 - $81,760	16,000 Added 101.61%	31,746 $90,000
Q1 2022 May 16, 2022	BUY	$5.02 - $10.47 $79,044 - $164,860	15,746 New	15,746 $79,000
Q1 2022 May 13, 2022	SELL	$5.02 - $10.47 $59,968 - $125,074	-11,946 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.95 - $16.88 $44,750 - $84,400	5,000 Added 71.98%	11,946 $119,000
Q3 2021 Nov 15, 2021	BUY	$12.2 - $16.75 $35,941 - $49,345	2,946 Added 73.65%	6,946 $90,000
Q2 2021 Aug 13, 2021	BUY	$12.03 - $17.51 $48,120 - $70,040	4,000 New	4,000 $56,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $563M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.